Merck Other Long-Term Assets 2012-2026 | MRK

Merck other long-term assets for the quarter ending March 31, 2026 were $18.333B, a 26.93% increase year-over-year.

  • Merck other long-term assets for 2024 were $16.044B, a 33.74% increase from 2023.
  • Merck other long-term assets for 2023 were $11.996B, a 25.9% increase from 2022.
  • Merck other long-term assets for 2022 were $9.528B, a 17.73% decline from 2021.

Merck Other Long-Term Assets 2012-2026 | MRK

  • Merck other long-term assets for 2024 were $16.044B, a 33.74% increase from 2023.
  • Merck other long-term assets for 2023 were $11.996B, a 25.9% increase from 2022.
  • Merck other long-term assets for 2022 were $9.528B, a 17.73% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B